Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of APOL1-mediated kidney disease

Economic impact of APOL1-mediated kidney disease on families

5 evidence topics · 6 sources

APOL1-specific family cost studies

No evidence found.